Saliva as a Diagnostic Tool in Oral Malignancies.
References
1. Santarelli A, Lo Russo L, Bambini F, Campisi G, Lo Muzio L. New perspectives in medical approach to therapy of head and neck squamous cell carcinoma. Minerva Stomatol. 2009;58(9):445–52.
2. Sannam Khan R, Khurshid Z, Akhbar S, Faraz Moin S. Advances of Salivary Proteomics in Oral Squamous Cell Carcinoma (OSCC) Detection: An Update. Proteomes. 2016;4(4):pii: E41.
3. Jiang J, Park NJ, Hu S, Wong DT. A universal pre-analytic solution for concurrent stabilization of salivary proteins, RNA and DNA at ambient temperature. Arch Oral Biol. 2009;54(3):268–73.
4. Khurshid Z, Mali M, Naseem M, Najeeb S, Zafar MS. Human Gingival Crevicular Fluids (GCF) Proteomics: An Overview. Dent J. 2017;5(1):pii: E12.
5. Editorial G. Salivaomics: An Emerging Approach in Dentistry. J Pak Dent Assoc. 2016;25:1–3.
6. Khurshid Z. Salivary point-of-care technology. Eur J Dent. 2018;12(1):1–2.
7. Khurshid Z, Moin SF, Khan RS, Agwan MAS, Alwadaani AH, Zafar MS. Human salivary protein extraction from RNAPro·SAL™, Pure·SAL™, and passive drooling method. Eur J Dent. 2017;11(3):385–9.
8. Khurshid Z, Zohaib S, Najeeb S, Zafar MS, Slowey PD, Almas K. Human Saliva Collection Devices for Proteomics: An Update. Int J Mol Sci. 2016;17(6):pii: E846.
9. Khurshid Z. Future of Oral Proteomics. J Oral Res. 2018;7(2):42–3.
10. Khurshid Z, Zohaib S, Najeeb S, Zafar MS, Rehman R, Rehman IU. Advances of Proteomic Sciences in Dentistry. Int J Mol Sci. 2016;17(5):pii: E728.
11. Urdea MS, Neuwald PD, Greenberg BL, Glick M, Galloway J, Williams D, Wong DT. Saliva, diagnostics, and dentistry. Adv Dent Res. 2011;23(4):353–9.
12. Warnakulasuriya S, Soussi T, Maher R, Johnson N, Tavassoli M. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients. J Pathol. 2000;192(1):52–7.
13. Zöller J, Fiehn W, Mende U, Hotz G. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck]. Dtsch Z Mund Kiefer Gesichtschir. 1990;14(4):245–9.
14. Mizukawa N, Sugiyama K, Fukunaga J, Ueno T, Mishima K, Takagi S, Sugahara T. Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients. Anticancer Res. 1998;18(6B):4645–9.
15. Khurshid Z, Zafar MS, Naseem M, Khan RS, Najeeb S. Human Oral Defensins Antimicrobial Peptides: A Future Promising Antimicrobial Drug. Curr Pharm Des. 2018;24(10):1130–7.
16. Badawi AF, Hosny G, el-Hadary M, Mostafa MH. Salivary nitrate, nitrite and nitrate reductase activity in relation to risk of oral cancer in Egypt. Dis Markers. 1998;14(2):91–7.
17. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000;287(5460):2017–9.
18. St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, Shi W, Qi F, Wu B, Sinha U, Jordan R, Wolinsky L, Park NH, Liu H, Abemayor E, Wong DT. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130(8):929–35.
19. Sahibzada HA, Khurshid Z, Khan RS, Naseem M, Siddique KM, Mali M, Zafar MS. Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer. Diagnostics. 2017;7(2):pii: E21.
20. Khan RS, Khurshid Z, Yahya Ibrahim Asiri F. Advancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid Biopsy. Diagnostics. 2017;7(3):pii: E39.
2. Sannam Khan R, Khurshid Z, Akhbar S, Faraz Moin S. Advances of Salivary Proteomics in Oral Squamous Cell Carcinoma (OSCC) Detection: An Update. Proteomes. 2016;4(4):pii: E41.
3. Jiang J, Park NJ, Hu S, Wong DT. A universal pre-analytic solution for concurrent stabilization of salivary proteins, RNA and DNA at ambient temperature. Arch Oral Biol. 2009;54(3):268–73.
4. Khurshid Z, Mali M, Naseem M, Najeeb S, Zafar MS. Human Gingival Crevicular Fluids (GCF) Proteomics: An Overview. Dent J. 2017;5(1):pii: E12.
5. Editorial G. Salivaomics: An Emerging Approach in Dentistry. J Pak Dent Assoc. 2016;25:1–3.
6. Khurshid Z. Salivary point-of-care technology. Eur J Dent. 2018;12(1):1–2.
7. Khurshid Z, Moin SF, Khan RS, Agwan MAS, Alwadaani AH, Zafar MS. Human salivary protein extraction from RNAPro·SAL™, Pure·SAL™, and passive drooling method. Eur J Dent. 2017;11(3):385–9.
8. Khurshid Z, Zohaib S, Najeeb S, Zafar MS, Slowey PD, Almas K. Human Saliva Collection Devices for Proteomics: An Update. Int J Mol Sci. 2016;17(6):pii: E846.
9. Khurshid Z. Future of Oral Proteomics. J Oral Res. 2018;7(2):42–3.
10. Khurshid Z, Zohaib S, Najeeb S, Zafar MS, Rehman R, Rehman IU. Advances of Proteomic Sciences in Dentistry. Int J Mol Sci. 2016;17(5):pii: E728.
11. Urdea MS, Neuwald PD, Greenberg BL, Glick M, Galloway J, Williams D, Wong DT. Saliva, diagnostics, and dentistry. Adv Dent Res. 2011;23(4):353–9.
12. Warnakulasuriya S, Soussi T, Maher R, Johnson N, Tavassoli M. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients. J Pathol. 2000;192(1):52–7.
13. Zöller J, Fiehn W, Mende U, Hotz G. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck]. Dtsch Z Mund Kiefer Gesichtschir. 1990;14(4):245–9.
14. Mizukawa N, Sugiyama K, Fukunaga J, Ueno T, Mishima K, Takagi S, Sugahara T. Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients. Anticancer Res. 1998;18(6B):4645–9.
15. Khurshid Z, Zafar MS, Naseem M, Khan RS, Najeeb S. Human Oral Defensins Antimicrobial Peptides: A Future Promising Antimicrobial Drug. Curr Pharm Des. 2018;24(10):1130–7.
16. Badawi AF, Hosny G, el-Hadary M, Mostafa MH. Salivary nitrate, nitrite and nitrate reductase activity in relation to risk of oral cancer in Egypt. Dis Markers. 1998;14(2):91–7.
17. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000;287(5460):2017–9.
18. St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, Shi W, Qi F, Wu B, Sinha U, Jordan R, Wolinsky L, Park NH, Liu H, Abemayor E, Wong DT. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130(8):929–35.
19. Sahibzada HA, Khurshid Z, Khan RS, Naseem M, Siddique KM, Mali M, Zafar MS. Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer. Diagnostics. 2017;7(2):pii: E21.
20. Khan RS, Khurshid Z, Yahya Ibrahim Asiri F. Advancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid Biopsy. Diagnostics. 2017;7(3):pii: E39.
Published
2018-08-09
How to Cite
MINHAS, Sadia; KHURSHID, Zohaib.
Saliva as a Diagnostic Tool in Oral Malignancies..
Journal of Oral Research, [S.l.], v. 7, n. 8, p. 276-277, aug. 2018.
ISSN 0719-2479.
Available at: <https://joralres.com/index.php/JOralRes/article/view/joralres.2018.071>. Date accessed: 18 apr. 2024.
doi: https://doi.org/10.17126/joralres.2018.071.
Issue
Section
Editorials
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. © 2024.
